Home    Back

Pfd    (DrugBank: -)

2 diseases
IDDisease name (Link within this page)Number of trials
51Scleroderma1
298Hereditary pancreatitis2

51. Scleroderma    [ 466 clinical trials,   536 drugs,   (DrugBank: 142 drugs),   110 drug target genes,   210 drug target pathways]
Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 466 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03221257
(ClinicalTrials.gov)		November 28, 201712/7/2017Scleroderma Lung Study III - Combining Pirfenidone With MycophenolateScleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung DiseaseScleroderma, Systemic;Interstitial Lung DiseaseDrug: Pirfenidone (PFD);Drug: Placebo (Plac);Drug: Mycophenolate Mofetil (MMF)Michael RothUniversity of Michigan;Genentech, Inc.;University of California, Los AngelesActive, not recruiting18 YearsN/AAll150Phase 2United States

298. Hereditary pancreatitis    [ 93 clinical trials,   168 drugs,   (DrugBank: 51 drugs),   48 drug target genes,   134 drug target pathways]
Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 93 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1JPRN-UMIN000028150
2017/07/1010/07/2017Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker Healthy volunteers, patients with chronic pancreatitis, patients with chronic hepatitisBlood test and PFD testYokohama City UniversityNULLRecruiting20years-old75years-oldMale and Female200Not selectedJapan
2JPRN-UMIN000008340
2012/08/0104/07/2012pancreatic exocrine function with non-contrast MRI:Visualization by Means of MRCP with Spatially Selective Inversion-Recovery Pulse Chronic pancreatitisMRCP/PFD test
MRCP		the Department of Diagnostic Radiology Kawasaki Medical SchoolNULLComplete: follow-up completeNot applicableNot applicableMale and Female40Not selectedJapan